Only 7% of pharma research projects target children below 12: report
The Hindu Business line writes about the latest analysis from the Access to Medicine Foundation, which investigates the access gap for paediatric medicines.
Date
29 March 2021
The article delves into the Foundation's latest analysis on paediatric medicine. Chidren in low- and middle-income countries are disproportionately impacted by the lack of life-saving medicines for treatable illnesses, but continue to remain last in line for new chid-friendly formulas.
Claudia Martinez, Research Programme Manager for the Access to Medicine Index, and Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, are quoted in the article.